Gene Therapy & Gene Editing
Part of Healthcare - Genomics & Precision Medicine
 VRTX | Vertex Pharmaceuticals Inc | $127.9b | $517.46 | -1.2% | 940.8K |
 REGN | Regeneron Pharmaceuticals Inc | $75.7b | $809.64 | +0.4% | 322.4K |
 INSM | Insmed, Inc. | $24.3b | $94.06 | -0.0% | 3.0M |
 BMRN | BioMarin Pharmaceuticals Inc | $11.1b | $56.00 | -0.4% | 1.9M |
 KRYS | Krystal Biotech, Inc. Common Stock | $9.5b | $312.94 | +0.7% | 182.3K |
 CRSP | CRISPR Therapeutics AG | $5.4b | $48.98 | -0.8% | 850.2K |
 FOLD | Amicus Therapeutics, Inc | $4.5b | $14.49 | +0.0% | 3.5M |
 PGEN | Precigen, Inc. Common Stock | $3.1b | $6.05 | -2.3% | 2.1M |
 BEAM | Beam Therapeutics Inc. Common Stock | $2.5b | $23.78 | -1.0% | 746.9K |
 VCEL | Vericel Corporation | $2.1b | $43.03 | +1.1% | 551.5K |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | $1.8b | $17.75 | +1.5% | 1.0M |
 BLFS | BioLife Solutions Inc. | $1.8b | $38.60 | 0.0% | N/A |
 NTLA | Intellia Therapeutics, Inc | $1.7b | $11.28 | +0.4% | 1.6M |
 QURE | uniQure N.V. | $1.6b | $21.83 | -3.5% | 894.2K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | $1.5b | $4.05 | +1.0% | 1.4M |
 MGTX | MeiraGTx Holdings plc Ordinary Shares | $1.0b | $9.19 | -0.4% | 514.9K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $36.82 | -0.1% | 315.9K |
 CYRX | CryoPort, Inc. Common Stock | $0.9b | $17.80 | -1.1% | 338.9K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $2.34 | +1.3% | 1.3M |
 DSGN | Design Therapeutics, Inc. Common Stock | $0.8b | $10.33 | +0.8% | 258.1K |
 FDMT | 4D Molecular Therapeutics, Inc. Common Stock | $0.8b | $11.04 | +2.2% | 962.2K |
 SLDB | Solid Biosciences Inc. Common Stock | $0.7b | $5.82 | -1.7% | 771.6K |
 PRME | Prime Medicine, Inc. Common Stock | $0.5b | $3.62 | -1.5% | 2.3M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.5b | $1.22 | -2.4% | 10.2M |
 NGNE | Neurogene, Inc. Common Stock | $0.5b | $23.57 | +0.1% | 102.1K |
 RGNX | REGENXBIO Inc. | $490.5m | $6.58 | -1.6% | 992.8K |
 EDIT | Editas Medicine, Inc. Common Stock | $402.4m | $2.40 | +0.4% | 1.2M |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $384.7m | $5.25 | -2.4% | 721.4K |
 IRD | Opus Genetics, Inc. Common Stock | $381.0m | $3.34 | -4.3% | 1.4M |
 OCGN | Ocugen, Inc. Common Stock | $345.9m | $0.71 | -3.1% | 7.9M |
 CABA | Cabaletta Bio, Inc. Common Stock | $339.1m | $1.38 | -8.8% | 5.8M |
 BNTC | Benitec Biopharma Inc. Common Stock | $313.2m | $8.60 | -0.8% | 79.2K |
 LXEO | Lexeo Therapeutics, Inc. Common Stock | $289.8m | $2.71 | -3.2% | 990.8K |
 ABEO | Abeona Therapeutics Inc. Common Stock | $287.6m | $4.36 | -1.8% | 354.0K |
 RCKT | Rocket Pharmaceuticals, Inc. Common Stock | $281.0m | $2.27 | -0.7% | 1.4M |
 TRDA | Entrada Therapeutics, Inc. Common Stock | $209.5m | $4.75 | +7.5% | 551.8K |
 DTIL | Precision BioSciences, Inc. Common Stock | $174.2m | $6.40 | -3.5% | 242.1K |
 VYGR | Voyager Therapeutics, Inc. Common Stock | $151.0m | $1.77 | +0.9% | 1.5M |
 KRRO | Korro Bio, Inc. Common Stock | $142.0m | $13.14 | +0.7% | 163.8K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $130.8m | $0.52 | -7.7% | 1.9M |
 CBUS | Cibus, Inc. Class A Common Stock | $130.7m | $1.39 | -0.7% | 49.9K |
 ENGN | enGene Therapeutics Inc. Common Stock | $130.0m | $1.57 | +1.3% | 653.1K |
 TNYA | Tenaya Therapeutics, Inc. Common Stock | $126.5m | $0.41 | +5.4% | 3.4M |
 INO | Inovio Pharmaceuticals, Inc. | $119.9m | $0.89 | -2.8% | 2.8M |
 GNLX | Genelux Corporation Common Stock | $115.8m | $1.94 | -4.5% | 490.4K |
 MXCT | MaxCyte, Inc. Common Stock | $110.4m | $1.49 | +8.6% | 1.1M |
 SGMO | Sangamo Therapeutics, Inc. Common Stock | $83.3m | $0.18 | -17.5% | 6.9M |
 GRML | Greenland Mines Ltd. Common Stock | $60.0m | $5.72 | +0.5% | 609.4K |
 TIL | Instil Bio, Inc. Common Stock | $49.0m | $5.67 | -0.8% | 36.3K |
 MGX | Metagenomi Therapeutics, Inc. Common Stock | $38.5m | $0.76 | -4.1% | 208.5K |